Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion

• Status: Completed
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Treatments: Mifepristone

Criteria

Inclusion Criteria:

• Women 18 years and older

• seeking medical abortion services

• in general good health

• assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken

• eligible for medical abortion according to clinician and center standards.

Exclusion Criteria:

• will be followed up by beta HCG and not ultrasound